PPD in the News
Complex biomolecules require analytical evolution
William Bakewell and Marc Wolman of PPD® Laboratories’ GMP lab discuss how the structure and activity of complex biotherapeutic molecules require sensitive analytical technologies.
Spearheading the fight against infectious diseases and emerging outbreaks
The authors explain how high throughput molecular biomarker technologies combined with bioinformatics have been successfully used to assess infectious agents.
Preparing for data transparency requirements of the new EU CTR
The authors discuss some steps organizations must take now to ensure readiness for the application of the EU Clinical Trial Regulation.
Good CROs Make Dream Teams, Great CROs Make Dynasties
Elisha Talley-Roithner outlines some of the reasons for considering outsourcing opportunities with CROs.
Development strategies for cell and gene therapy methods
The authors discuss how the increase in regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.
CRO industry update
PPD’s Les Enterline explains that COVID-19 has accelerated the need for clients to have rapid access to additional highly trained professionals to support their pipelines in what already was a highly competitive market.
PPD cuts the ribbon on new clinical research lab in Suzhou, China
PPD held a grand opening ceremony for its new multipurpose laboratory in Suzhou, China, to support Western and China-based pharmaceutical and biotech companies managing China research studies.
PPD opens clinical research lab in Suzhou, China
The 67,000-square-foot facility offers bioanalytical, biomarker and vaccine laboratory services to support trials across all phases of pharmaceutical development.
PPD adds cell and gene therapy testing capabilities to Irish site
PPD is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing.
